B

Bio-FD&C Co Ltd
KOSDAQ:251120

Watchlist Manager
Bio-FD&C Co Ltd
KOSDAQ:251120
Watchlist
Price: 13 270 KRW 2.47% Market Closed
Market Cap: 113.2B KRW
Have any thoughts about
Bio-FD&C Co Ltd?
Write Note

Relative Value

The Relative Value of one Bio-FD&C Co Ltd stock under the Base Case scenario is 16 792.11 KRW. Compared to the current market price of 13 270 KRW, Bio-FD&C Co Ltd is Undervalued by 21%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
16 792.11 KRW
Undervaluation 21%
Relative Value
Price
B
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
51
vs Industry
53
Median 3Y
8.2
Median 5Y
8.2
Industry
7.7
Forward
6.6
vs History
51
vs Industry
8
Median 3Y
26.2
Median 5Y
26.2
Industry
22.7
Forward
23.8
vs History
57
vs Industry
7
Median 3Y
23
Median 5Y
23
Industry
21.6
vs History
37
vs Industry
2
Median 3Y
47.8
Median 5Y
47.8
Industry
25.2
vs History
54
vs Industry
37
Median 3Y
2.3
Median 5Y
2.3
Industry
2.5
vs History
51
vs Industry
52
Median 3Y
5.9
Median 5Y
5.9
Industry
7.7
Forward
4.2
vs History
48
vs Industry
45
Median 3Y
8.1
Median 5Y
8.1
Industry
9
vs History
48
vs Industry
8
Median 3Y
14.7
Median 5Y
14.7
Industry
4.2
Forward
10.6
vs History
48
vs Industry
7
Median 3Y
18.1
Median 5Y
18.1
Industry
4.1
Forward
12.9
vs History
54
vs Industry
9
Median 3Y
16.2
Median 5Y
16.2
Industry
5.7
vs History
22
vs Industry
6
Median 3Y
21.7
Median 5Y
21.7
Industry
3.6
vs History
54
vs Industry
32
Median 3Y
4.6
Median 5Y
4.6
Industry
4.6

Multiples Across Competitors

Competitors Multiples
Bio-FD&C Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Bio-FD&C Co Ltd
KOSDAQ:251120
113.2B KRW 6.9 21.9 11.5 14.2
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 888 840.5 -180 080 -218 674.5 -216 179.2
US
Abbvie Inc
NYSE:ABBV
314.7B USD 5.7 61.9 15.4 23.7
US
Amgen Inc
NASDAQ:AMGN
157B USD 4.8 37.1 17.4 32.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.2B USD 4 890.3 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 859.4 -474.5 -516.7 -502.9
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 6 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.9 -54.9 -59 -53.2
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.6 -130.6 -105.1 -76.6
P/E Multiple
Earnings Growth
KR
B
Bio-FD&C Co Ltd
KOSDAQ:251120
Average P/E: 177
21.9
37%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -180 080 N/A
US
Abbvie Inc
NYSE:ABBV
61.9
412%
US
Amgen Inc
NASDAQ:AMGN
37.1
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
890.3
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -474.5 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.9 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -130.6 N/A
EV/EBITDA Multiple
EBITDA Growth
KR
B
Bio-FD&C Co Ltd
KOSDAQ:251120
Average EV/EBITDA: 16.4
11.5
60%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -218 674.5 N/A
US
Abbvie Inc
NYSE:ABBV
15.4
28%
US
Amgen Inc
NASDAQ:AMGN
17.4
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
38%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -516.7 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -105.1 N/A
EV/EBIT Multiple
EBIT Growth
KR
B
Bio-FD&C Co Ltd
KOSDAQ:251120
Average EV/EBIT: 21.3
14.2
71%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 179.2 N/A
US
Abbvie Inc
NYSE:ABBV
23.7
88%
US
Amgen Inc
NASDAQ:AMGN
32.9
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -502.9 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.2 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.6 N/A

See Also

Discover More
Back to Top